ArticleNPJ precision oncology2024

Complete response to fifth-line anti-PD-1 rechallenge in fumarate hydratase-mutated papillary renal cell carcinoma.

Isabella Portugal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.